Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1995 3
1996 2
2000 1
2001 2
2002 1
2003 4
2004 2
2006 2
2007 1
2009 2
2010 2
2011 4
2012 3
2013 7
2014 7
2015 13
2016 12
2017 11
2018 8
2019 7
2020 16
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 32467177

103 results
Results by year
Filters applied: . Clear all
Page 1
Industry One-Voice-of-Quality (1VQ) Solutions: Effective Management of Post-Approval Changes in the Pharmaceutical Quality System (PQS)-through Enhanced Science and Risk-Based Approaches.
Ramnarine E, Vinther A, Bruhin K, Tovar C, Colao M. Ramnarine E, et al. PDA J Pharm Sci Technol. 2020 Jul-Aug;74(4):456-467. doi: 10.5731/pdajpst.2020.011734. Epub 2020 May 28. PDA J Pharm Sci Technol. 2020. PMID: 32467177
Solving the Global Continual Improvement and Innovation Challenge: How an Effective Pharmaceutical Quality System Can Transform Post-Approval Change Management.
Vinther A, Ramnarine E. Vinther A, et al. PDA J Pharm Sci Technol. 2019 Sep-Oct;73(5):517-521. doi: 10.5731/pdajpst.2019.010827. Epub 2019 Aug 16. PDA J Pharm Sci Technol. 2019. PMID: 31420505
Enabling ICH Q10 Implementation--Part 1. Striving for Excellence by Embracing ICH Q8 and ICH Q9.
Calnan N, O'Donnell K, Greene A. Calnan N, et al. PDA J Pharm Sci Technol. 2013 Nov-Dec;67(6):581-600. doi: 10.5731/pdajpst.2013.00940. PDA J Pharm Sci Technol. 2013. PMID: 24265300
Managing Excipient Supplier Name and Address Changes in the Pharmaceutical Quality System.
Rolke R, Ramnarine E, Vinther A, Sawant A. Rolke R, et al. PDA J Pharm Sci Technol. 2020 Mar-Apr;74(2):286-288. doi: 10.5731/pdajpst.2019.011239. Epub 2020 Mar 16. PDA J Pharm Sci Technol. 2020. PMID: 32179712
Knowledge Management as a Pharmaceutical Quality System Enabler: How Enhanced Knowledge Transfer can help close the Q10 to Q12 Gap.
Lipa MJ, Greene A, Calnan N. Lipa MJ, et al. PDA J Pharm Sci Technol. 2020 Jul 16:pdajpst.2020.011825. doi: 10.5731/pdajpst.2020.011825. Online ahead of print. PDA J Pharm Sci Technol. 2020. PMID: 32675306
Demonstrating Pharmaceutical Quality System Effectiveness and Driving Continual Improvement: Evidence-Based Risk Reduction.
Ramnarine E, O'Donnell K. Ramnarine E, et al. PDA J Pharm Sci Technol. 2018 May-Jun;72(3):338-345. doi: 10.5731/pdajpst.2017.008524. Epub 2018 Apr 18. PDA J Pharm Sci Technol. 2018. PMID: 29669814
ISO 9001:2015 vs ICH Q10 - A Comparison.
Aaberg C, Dahmen H, Davies C, Sandau PL, Srinivasan R. Aaberg C, et al. PDA J Pharm Sci Technol. 2020 Sep 30:pdajpst.2020.011692. doi: 10.5731/pdajpst.2020.011692. Online ahead of print. PDA J Pharm Sci Technol. 2020. PMID: 32999074
Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer.
Anyakora C, Ekwunife O, Alozie F, Esuga M, Ukwuru J, Onya S, Nwokike J. Anyakora C, et al. BMC Health Serv Res. 2017 Sep 18;17(1):665. doi: 10.1186/s12913-017-2610-8. BMC Health Serv Res. 2017. PMID: 28923044 Free PMC article.
The FDA Unapproved Drugs Initiative: An Observational Study of the Consequences for Drug Prices and Shortages in the United States.
Gupta R, Dhruva SS, Fox ER, Ross JS. Gupta R, et al. J Manag Care Spec Pharm. 2017 Oct;23(10):1066-1076. doi: 10.18553/jmcp.2017.23.10.1066. J Manag Care Spec Pharm. 2017. PMID: 28944731
A QRM Discussion of Microbial Contamination of Non-sterile Drug Products, Using FDA and EMA Warning Letters Recorded between 2008 and 2016.
Santos AMC, Doria MS, Meirinhos-Soares L, Almeida AJ, Menezes JC. Santos AMC, et al. PDA J Pharm Sci Technol. 2018 Jan-Feb;72(1):62-72. doi: 10.5731/pdajpst.2016.007252. Epub 2017 Dec 14. PDA J Pharm Sci Technol. 2018. PMID: 29242394
103 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback